Its ligand, CD70, is only transiently expressed on activated T-cells, B-cells, and mature dendritic cells [56], while its overexpression has been reported in renal cell carcinoma [57] and hematological malignancies [58]. This evidence concerns the gene CD70 and renal cell carcinoma.